Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Bendamustine Hydrochloride × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Head and Neck Neoplasms 1 Breast Neoplasms, Male 1

Interventions

Paclitaxel 50 Capecitabine 50 Trastuzumab 38 Fulvestrant 30 Cyclophosphamide 27 pembrolizumab 26 Carboplatin 26 Gemcitabine 23 palbociclib 19 Letrozole 19 Docetaxel 19 Lapatinib 18 Bevacizumab 18 exemestane 17 eribulin 15 Everolimus 14 abemaciclib 13 Vinorelbine 13 Nivolumab 12 Magnetic Resonance Spectroscopy 12 Anastrozole 12 trastuzumab deruxtecan 11 Zoledronic Acid 11 Doxorubicin 11 Cisplatin 11 Albumin-Bound Paclitaxel 11 olaparib 10 Tamoxifen 10 Specimen Handling 10 Radiotherapy 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00661739 2011-09-02

RiTa

GBG Forschungs GmbH

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡